Ramin Najafi is CEO & 10% at NovaBay Pharmaceuticals, Inc. (NBY). They have made 17 open-market trades across 1 company since 2008, most recently 2015-08-20.
CIK 0001410081
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
17 open-market purchases totalling $242K since 2008, never a sale. Across 17 scored buys the stock is up 3.6% at ninety days, and 3.3 points ahead of the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| NBY | 12,000 | $23K |
Shares reported on the most recent Form 4, priced at the 2015-08-21 close.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 100% | 100% | 100% |
| Avg Move | +12.3% | +3.6% | +3.6% |
| Alpha | +18.1% | +3.3% | +3.3% |
| Scored | 17 | 17 | 17 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NBY | BUY | 2015-08-19 | 2015-08-21 | $0.47 | $6K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2015-03-03 | 2015-03-05 | $0.60 | $100K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-12-12 | 2014-12-15 | $0.65 | $33K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-12-11 | 2014-12-11 | $0.60 | $12K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-12-05 | 2014-12-08 | $0.65 | $16K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2014-12-02 | 2014-12-04 | $0.71 | $13K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2012-12-06 | 2012-12-10 | $1.24 | $25K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2012-05-29 | 2012-05-30 | $0.96 | $6K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2012-05-25 | 2012-05-29 | $0.99 | $3K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2011-08-16 | 2011-08-16 | $0.85 | $9K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2011-05-27 | 2011-05-31 | $1.59 | $795 | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2011-05-26 | 2011-05-27 | $1.60 | $800 | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2011-05-24 | 2011-05-26 | $1.71 | $4K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2009-08-28 | 2009-08-28 | $1.92 | $2K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2008-12-10 | 2008-12-11 | $1.14 | $570 | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2008-09-02 | 2011-02-01 | $1.98 | $2K | +12.3% | +3.6% | +3.6% |
| NBY | BUY | 2008-03-14 | 2008-03-18 | $2.71 | $10K | +12.3% | +3.6% | +3.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.